Overview

Study Assessing Double-masked Uveitis Treatment

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of intravitreal injections of DE-109 ophthalmic solution.
Phase:
Phase 3
Details
Lead Sponsor:
Santen Inc.
Treatments:
Everolimus
Ophthalmic Solutions
Sirolimus